Pathological features of the differentiation landscape in esophageal squamous cell cancer and their correlations with prognosis

Pathological features of the differentiation landscape in esophageal squamous cell cancer and their correlations with prognosis

BackgroundFor esophageal squamous cell carcinoma (ESCC), universally accepted pathological criteria for classification by differentiation degree are lacking. Tumor budding, single-cell invasion, and nuclear grade, recognized as prognostic factors in other carcinomas, have rarely been investigated fo...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jiaying Deng, Lei Zhang, Zezhou Wang, Bin Li, Jiaqing Xiang, Longfei Ma, Hongcheng Zhu, Yuan Li, Kuaile Zhao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-12-01
Series:	Frontiers in Oncology
Subjects:	differentiation pathological features esophageal squamous cell carcinoma nuclear diameter prognosis
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1442212/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

CT-based delta-radiomics for predicting pathological response to neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma: a multicenter study
by: Yuting Zheng, et al.
Published: (2024-12-01)

The epidemiological trends and predictions of esophageal squamous cell carcinoma and gastroesophageal junction carcinoma: an Australian population-based study
by: Shalika Bohingamu Mudiyanselage, et al.
Published: (2024-12-01)

Prognostic role of the pathological status following neoadjuvant chemoradiotherapy and surgery in esophageal squamous cell carcinoma
by: Xiaofeng Duan, et al.
Published: (2025-01-01)

Comparison of radiation esophagitis associated with daytime versus evening radiotherapy in patients with esophageal carcinoma
by: Yun Xing, et al.
Published: (2025-01-01)

Prognostic value of serum inflammatory markers in patients with esophageal squamous cell carcinoma undergoing surgery: a two-center retrospective cohort study
by: Yaqin Dong, et al.
Published: (2025-02-01)

Sirtuin1 (sirt1) regulates the glycolysis pathway and decreases cisplatin chemotherapeutic sensitivity to esophageal squamous cell carcinoma
by: Xuewen Yang, et al.
Published: (2024-12-01)

Radiotherapy and chemoradiotherapy for postoperative recurrence in patients with esophageal squamous cell carcinoma
by: Qing Liu, et al.
Published: (2024-08-01)

Identification of key genes to predict response to chemoradiotherapy and prognosis in esophageal squamous cell carcinoma
by: Yingying Cui, et al.
Published: (2024-11-01)

Characterization and dosimetric predictors for absolute lymphocyte count changes during neoadjuvant chemoradiotherapy with or without pembrolizumab for esophageal squamous cell carcinoma: an analysis of a prospective cohort
by: Wei-Xiang Qi, et al.
Published: (2025-01-01)

Survival outcome prediction of esophageal squamous cell carcinoma patients based on radiomics and mutation signature
by: Ting Yan, et al.
Published: (2025-01-01)

Perioperative tislelizumab with four cycles of neoadjuvant chemotherapy for resectable locally advanced esophageal squamous cell carcinoma: a phase 2 study
by: Na Zhou, et al.
Published: (2024-12-01)

Nomograms for predicting the prognosis in multiple primary esophageal squamous cell carcinoma
by: Kexi Wang, et al.
Published: (2024-12-01)

Efficacy and safety of camrelizumab combined with chemotherapy as second-line treatment for locally advanced, recurrent, or metastatic esophageal squamous cell carcinoma
by: Yinfang Gu, et al.
Published: (2025-02-01)

TAOK3 Facilitates Esophageal Squamous Cell Carcinoma Progression and Cisplatin Resistance Through Augmenting Autophagy Mediated by IRGM
by: Mingchuang Sun, et al.
Published: (2023-10-01)

Schwann cell reprogramming and Esophageal squamous cell carcinoma: analysis of transcriptome data
by: Roberta Karolline de Souza Lima, et al.
Published: (2024-12-01)

HLX07 alone or combined with serplulimab, cisplatin and 5‐fluorouracil for advanced esophageal squamous cell carcinoma: A phase 2 study
by: Yun Liu, et al.
Published: (2024-12-01)

Novel miRNA markers and their mechanism of esophageal squamous cell carcinoma (ESCC) based on TCGA
by: Ping Yuan, et al.
Published: (2024-11-01)

Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma
by: Xiaqin Zhang, et al.
Published: (2025-01-01)

Advancing precision medicine in esophageal squamous cell carcinoma using patient-derived organoids
by: Suya Shen, et al.
Published: (2024-12-01)

Salivary microbiome is associated with the response to chemoradiotherapy in initially inoperable patients with esophageal squamous cell carcinoma
by: Yuan He, et al.
Published: (2024-12-01)

Mechanism investigation of Forsythoside A against esophageal squamous cell carcinoma in vitro and in vivo
by: Yingying Yang, et al.
Published: (2024-12-01)

Characteristics of Esophageal Squamous Cell Carcinomas Based on Circumferential Localization
by: Natsuki Ishida, et al.
Published: (2024-12-01)

Implication of CCNG1 in radiosensitivity via the Wnt/β-catenin pathway in esophageal squamous cells
by: Yuxiang Zhang, et al.
Published: (2024-11-01)

The intratumoral landscape of T cell receptor repertoire in esophageal squamous cell carcinoma
by: Meng Yang, et al.
Published: (2024-11-01)

Arntl-induced upregulation of DUSP1 inhibits tumor progression in esophageal squamous cell carcinoma by inactivating ERK signaling
by: Jianjun Wang, et al.
Published: (2024-12-01)

Prognostic value of association of OCT4 with LEF1 expression in esophageal squamous cell carcinoma and their impact on epithelial‐mesenchymal transition, invasion, and migration
by: Yue Zhao, et al.
Published: (2018-08-01)

Spatial transcriptome profiling identifies DTX3L and BST2 as key biomarkers in esophageal squamous cell carcinoma tumorigenesis
by: Rutao Li, et al.
Published: (2024-12-01)

Integrating 18F-FDG PET/CT radiomics and body composition for enhanced prognostic assessment in patients with esophageal cancer
by: Yeye Zhou, et al.
Published: (2024-11-01)

From tumor microenvironment to emerging biomarkers: the reshaping of the esophageal squamous cell carcinoma tumor microenvironment by neoadjuvant chemotherapy combined with immunotherapy
by: Zhengzhou Qiu, et al.
Published: (2024-12-01)

Identification of a stable immunosuppressive molecular subtype in esophageal squamous cell carcinoma based on inflammation‐related genes
by: Yuan Yin, et al.
Published: (2024-12-01)

Lymphatic endothelial cell-mediated accumulation of CD177+Treg cells suppresses antitumor immunity in human esophageal squamous cell carcinoma
by: Min Ma, et al.
Published: (2024-12-01)

Association between dietary antioxidants, serum albumin/globulin ratio and quality of life in esophageal squamous cell carcinoma patients: a 7-year follow-up study
by: Juwei Zhang, et al.
Published: (2025-01-01)

The efficacy of neoadjuvant immunotherapy and lymphocyte subset predictors in locally advanced esophageal squamous cell carcinoma: A retrospective study
by: Ruotong Wang, et al.
Published: (2024-09-01)

The efficacy and safety of anlotinib plus PD-1 inhibitor in locally advanced/metastatic esophageal squamous cell carcinoma (ESCC) patients who progressed on prior immune checkpoint inhibitors (ICIs): a retrospective real-world study (NCT 04984096)
by: Xueru Zhu, et al.
Published: (2025-12-01)

Higher 3-year recurrence-free survival rate in patients with complete pathological remission following neoadjuvant chemotherapy plus immunotherapy for esophageal cancer: a two-center, propensity score matching study
by: Hai Zhang, et al.
Published: (2025-01-01)

Mid-term follow-up results of neoadjuvant sintilimab combined with chemotherapy for locally advanced resectable esophageal squamous cell carcinoma
by: Haibo Cai, et al.
Published: (2024-12-01)

Changes in PD-1 expression on T lymphocyte subsets and related immune indicators before and after definitive chemoradiotherapy for esophageal squamous cell carcinoma
by: Xueling Shi, et al.
Published: (2025-12-01)

Association between serum levels of 12 different cytokines and short-term efficacy of chemoradiotherapy in esophageal squamous cell carcinoma
by: Yaping Zhang, et al.
Published: (2025-01-01)

SPC25 upregulates CCND1 to promote the progression of esophageal squamous cell carcinoma by inhibiting MDM2-mediated E2F1 ubiquitination
by: Haoyao Jiang, et al.
Published: (2025-03-01)

Homologous recombination deficiency score is an independent prognostic factor in esophageal squamous cell carcinoma
by: Yulu Wang, et al.
Published: (2024-11-01)